ACTHX | ORNAX | ACTHX / ORNAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 39 years | 31 years | - |
Gain YTD | 5.530 | 4.432 | 125% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.98B | 9.97B | 80% |
Annual Yield % from dividends | 5.08 | 5.05 | 101% |
Returns for 1 year | 11.26 | 10.29 | 109% |
Returns for 3 years | -3.61 | -1.64 | 221% |
Returns for 5 years | 5.99 | 11.34 | 53% |
Returns for 10 years | 39.69 | 35.62 | 111% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CMGVX | 33.65 | 0.30 | +0.90% |
Columbia Select Mid Cap Gro Fd I2 | |||
CUHAX | 11.54 | 0.10 | +0.87% |
Victory US 500 Enh Vol Wtd Idx A | |||
TLAFX | 13.98 | 0.06 | +0.43% |
Transamerica Large Core ESG R4 | |||
MEMFX | 30.63 | 0.09 | +0.29% |
MFS Emerging Markets Equity R2 | |||
JNUSX | 14.77 | N/A | N/A |
JPMorgan Developed International Value L |